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A formal gluten challenge is rarely
indicated, particularly if serology is infor-
mative and the biopsy characteristic, but
this may be helpful in difficult cases,
particularly if there is diagnostic uncer-
tainty (eg, lack of clarity about the initial
diagnosis, gluten exclusion with no
biopsy). The challenge should be super-
vised by a paediatric dietician. Relapse can
occur many months after the challenge.
There is very little data on the outcome
of coeliac disease in children who are
asymptomatic at presentation and picked
up through screening, although a prag-
matic presumption that the same long-
term health benefits occur as in children
symptomatic at diagnosis and therefore
the recommendation is that all biopsy
positive children should be treated. There
is some evidence that children apparently
asymptomatic at diagnosis have mild
impairment of growth and are more likely
to have symptoms (irritability, lethargy,
distension and gas) than control sub-
jects.15 It is likely, therefore, that some
patients are considered asymptomatic
when they are not with ill health, only
being noticed in retrospect.
Type 1 diabetes has been the most
widely studied with respect to high-risk
screening and outcome, with the preva-
lence of coeliac disease in children with
type 1 diabetes being around 4%.16 There
is no evidence for an improvement in
diabetic control short term. The medium
and longer term effects of diabetic control
are also unknown; in particular, it is
unclear whether treatment of coeliac
disease impacts on the potential to
develop other autoimmune conditions.
It is important to remember that
children in high-risk groups whose
serology is initially negative on screen-
ing may develop a positive serology
subsequently. It is sensible to repeat
testing if children at high risk develop
suspicious symptoms.
The NASPGHAN recommends that
screening should begin at 3 years in
asymptomatic, high-risk children who
have been on an adequate gluten-con-
taining diet for at least 1 year before
testing.2 There is no consensus on how
often screening should be carried out.
Guidance from the National Institute of
Clinical Excellence (UK) recommends
screening those with type 1 diabeties at
diagnosis and then every 3 years.17
It is clearly necessary to have a low
threshold to investigate for coeliac disease
in a child with either frank or occult gut
symptoms. It should be a routine part of
the initial screening in children of short
stature. It is crucial that the diagnosis is
made correctly, and a trial of gluten
exclusion in children in whom the diag-
nosis is suspected is not recommended.
The high prevalence of coeliac disease is a
major healthcare issue and is relevant to
healthcare planning. We need to know
the natural history of undetected coeliac
disease to determine, whether we should
screen the whole population or high-risk
groups or only those who are sympto-
matic. Until these issues are resolved, we,
as the team from Cardiff emphasise, must
maintain a high index of suspicion for
this condition so that the potential
problems associated with untreated coe-
liac disease can be prevented.
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100 years of telemedicine
A
lthough hard to believe, this year
we celebrate the 100th anniver-
sary of telemedicine. The term
telemedicine was coined in the 1970s
by the American Thomas Bird and,
literally translated, means ‘‘healing at
a distance’’ (from Latin ‘‘medicus’’ and
Greek ‘‘tele’’). However, the origins of
this evolving technology date back to
the early 20th century, when Willem
Einthoven, a Dutch physiologist, devel-
oped the first electrocardiograph in his
laboratory in Leiden. With the use of a
string galvanometer and telephone
wires, he recorded the electrical cardiac
signals of patients in a hospital 1K km
away. He stated: ‘‘Where there is a link,
actual and figurative, between labora-
tory and hospital, and collaboration
between physiologist and clinician, each
remaining master in his territory, there
one may fruitfully utilize these new
electrical methods of research’’.
Einthoven’s electrocardiograph was very
large but over the years was trans-
formed into a mobile or even portable
monitoring device. Nevertheless, he can
be regarded as the first clinician scien-
tist to develop and systematically apply
a technique that is very similar to
telemedicine in the modern sense.
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The results of his experiments were
published in 1906.1 During the 1920s,
Norwegian doctors provided advice for
sick ship crew members at sea via radio
link. In 1967, Bird and colleagues
established an audiovisual microwave
circuit between the Massachusetts
General Hospital in Boston, USA, and
the nearby Logan Airport. They con-
ducted and evaluated .1000 medical
consultations for airport employees and
travellers who were ill.2 Since then, the
number of scientific studies relating to
telehealth has steadily increased, and
many countries have launched their
own electronic health (e-health) pro-
grammes, which combine medical infor-
matics, public health and business.
Telemedicine constitutes a small part
of e-health and is particularly suitable for
large geographical areas with a sparse,
underserved population. Examples are
Canada, India and Norway.3–5
DEFINITION
The European Commission’s definition
of telemedicine is ‘‘rapid access to
shared and remote medical expertise
by means of telecommunication and
information technologies, no matter
where the patient or relevant informa-
tion is located’’. Two complementary
methods of transmitting data, images
and sound can be differentiated: (1)
the live technique, where the health
professional has direct video contact
with the patient; and (2) the store and
forward technique, where informa-
tion—for instance, an x ray—is acquired
in one location and reviewed in another
at a later stage. The Integrated Digital
Service Network (IDSN) and broadband
or global satellite networks, such as
Intelsat and Healthnet, are used for
high-speed data transmission. Most
current definitions of telemedicine
exclude medical advice given only via a
telephone.6 Telepaediatrics, a new
branch of telemedicine, enables doctors
and patients to access expert knowledge
and assessments, which otherwise could
be achieved only with great difficulty,
and which may not be financially
feasible. This new technology can also
assist paediatricians to fulfil their role as
leaders of multidisciplinary teams
through improved communication, edu-
cation and teaching.7 During a typical
telemedicine consultation, a paediatric
nurse practitioner or technician carries
out an examination or investigation at a
distant healthcare facility, while a gen-
eral paediatrician or paediatric subspe-
cialist in a tertiary care centre monitors
and evaluates the clinical findings or
test results on a television screen.
APPLICATIONS
Over the past few years, telemedicine
has been increasingly used for the
benefit of sick and disabled children,
mainly in feasibility studies funded by
research grants. Robinson et al8 set up
two telemedicine clinics in rural areas of
Texas, which were linked to the
University of Texas Medical Branch,
Texas, USA. A paediatric nurse con-
ducted developmental assessments on
269 children with special needs, which
were transmitted online to the evaluat-
ing team consisting of a neurodevelop-
mental paediatrician, various therapists,
a psychologist and a dietitian. In a
questionnaire survey, parents rated the
service provided over a distance as
satisfactory. The main benefits were
reduced time off work and savings in
travel costs.8 Several studies have inves-
tigated the possibility of performing
echocardiography by means of telecom-
munication technology in children,
including neonates. They found that
diagnoses were reached faster and with
the same accuracy as the face-to-face
encounter. Telepaediatric cardiology did
not, however, lead to an overall cost
reduction.9 10 Teleradiology programmes
have been in use since the 1970s, and
today, many hospitals have established
the picture archiving and communica-
tion system (PACS), which allows
access to paediatric x rays, computed
tomography, magnetic resonance ima-
ging and ultrasound scans. More
recently, concerns have been raised
regarding the disadvantages of distan-
cing the radiologist from the patient.11 12
Only a few research projects associated
with telemedicine have been conducted
in specialties related to paediatrics
which are visually intensive—for
instance, dermatology, clinical genetics
and pathology.6 Child and adolescent
psychiatry and child protection are
highly sensitive areas where telemedi-
cine may enable children to express
their feelings more openly and to report
disturbing experiences to healthcare
workers, but there is little research
evidence available in these areas.13 14 In
the UK, a child or a young person is able
to give evidence in court via a televideo
link. This means the child does not need
to be present in the same room as the
defendant, which can be very stressful.
COSTS
Setting up a new high-quality telemedi-
cine link is not inexpensive and there-
fore requires careful planning and
repeated auditing. Apart from television
monitors with integrated video and
hand-held cameras, special stetho-
scopes, auroscopes, ophthalmoscopes
and spirometers are available.
However, examples of low-cost telera-
diology projects can be found in devel-
oping countries which use digital
images sent via e-mail or personal
Figure 1 Cover article on telecare in the magazine Radio News from 1924 and state-of-the-art
telemedicine unit (courtesy of DJ Streveler (University of Hawaii, Hawaii, USA) and Tandberg
(Lysaker, Norway)).
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computers equipped with radiological
film digitisers and appropriate software,
and existing satellite links.15 In their
systematic review, Jennett et al16 exam-
ined 82 research papers relating to
paediatric telehealth. In all, 24 (30%)
of these articles provided reasonable
evidence for the socio-economic benefits
of telemedicine, as defined by accessi-
bility of services, decreased costs, client
satisfaction and quality of care.16 This
review shows that at present we cannot
determine whether the advantages of
telemedicine outweigh its disadvantages,
some of which are outlined below.
RISKS
Teleradiology can be regarded as a
paradigm for other applications of tele-
medicine owing to its long history and
the large number of studies carried out
in this discipline.11 12 15 17–19 Teleradiology
allows the transmission of radiological
images from remote hospitals to expert
radiologists in tertiary centres for eva-
luation and advice. This service can be
delivered 24 h a day and reduces the
need for transport of patients who can
be treated locally. Interdisciplinary case
conferences can be held between radi-
ologists and clinicians to discuss com-
plex images that are difficult to
interpret. A teleradiology service faces
several potential problems, which can be
divided into legal aspects, communica-
tion and quality assurance. The report-
ing radiologist must be registered with a
regulatory body in the European Union
and must adhere to European Union-
wide legislation regarding duty of care,
health and safety, patient confidential-
ity and radiation exposure. The National
Health Service (NHS) Trust purchasing
the service remains fully responsible for
the patient. Communication between
the referring clinician and the radiolo-
gist can have a considerable effect on
patient management, and standard tele-
radiology reduces the opportunity for a
discussion between professionals. In
addition, direct contact with the patient
is no longer possible, which may be
necessary for obtaining consent and to
explain clinical findings. Teleradiology
can compromise the quality and con-
tinuity of care if the reporting radiolo-
gist does not have complete access to the
relevant clinical information and if he or
she is not kept informed of the progress
made by the patient. It is also important
that the transmitted images be of a
consistently high quality.
With the advent of the computerised
administration of patient data, concerns
have been raised about their security
and confidentiality. In this respect,
telemedicine poses a specific risk as it
includes a recordable two-way audio-
visual transmission of sensitive personal
data from children, parents and health
professionals.17 18 Consequently, written
consent should be sought from the
parent or carer before every telemedi-
cine session, and every effort should be
made to comply with the national data
protection legislation. The Royal College
of Radiologists has produced extensive
guidance on this important area of
concern.19
RESEARCH
During the past decade, there has been a
drive in the UK towards satellite pae-
diatric ambulatory care units distributed
around large paediatric (tertiary) care
centres and staffed by general paedia-
tricians or paediatric nurse practitioners
and nurses. Telepaediatrics, which
includes computer-aided prescribing,
can help to ensure that a high standard
of care is maintained in these ambula-
tory care units.20 Currently, nurses are
able to independently prescribe and give
drugs to patients using patient group
directions—for instance, when giving
nebulised salbutamol to patients with
asthma. Alternatively, paediatricians
based in a district general hospital could
issue electronic prescriptions to children
in nurse-led units.21 22
There is a requirement for a uniform,
consistent and safe approach for devel-
oping paediatric telemedicine facilities
in the UK, which can be achieved only
through further qualitative and quanti-
tative research into this subject. The
following suggestions are examples of
where telemedicine could be applied,
but they are by no means exhaustive. In
certain situations it can be difficult for
general paediatricians to describe accu-
rately the severity of a child’s illness,
which often changes quickly, to their
colleagues in the paediatric intensive
care unit. A televideo link would allow
the paediatric intensivist to assess the
condition of the patient more accurately
and assist with further management,
thus improving the quality of care and
possibly reducing the number of retrie-
vals. In the UK, there are few supra-
regional craniofacial teams that have
the expertise to perform corrective sur-
gery on children with craniosynostoses.
A telemedicine consultation that
includes the local paediatrician, the
affected child and the specialist surgeon
could be used as a screening tool, and
may help to avoid long journeys. We
work in a geographically large National
Health Service Trust, which combines
three district general hospitals and
several community hospitals and
nurse-led units. The Trust has four
telemedicine units in operation for adult
medicine and is currently evaluating
their role in paediatrics.
CONCLUSION
On an international scale, paediatric
telemedicine has already made a posi-
tive contribution to the quality of
healthcare provided for children. We
believe that telepaediatrics can be
advantageous to children with acute
and chronic illnesses in the UK in
selected areas, but it must be evaluated
in comparison with traditional forms of
care through controlled trials (useful
websites: http://www.amdtelemedicine.
com, http://www.publictechnology.net,
http://www.teis.nhs.uk/). The important
issues of patient safety and confidenti-
ality, clinical accountability and cost
effectiveness have to be carefully con-
sidered before the introduction of this
evolving technology.
Arch Dis Child 2006;91:956–959.
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Searching for the Holy Grail of acute
otitis media
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Use of PCV7 causes a major shift in the microbiology of AOM
towards H influenzae, but the search for the Holy Grail of AOM
still remains elusive
F
or decades, investigators have been
searching for one of the Holy Grails
of acute otitis media (AOM)—that
is, an easy non-invasive marker that
would identify or even suggest the
specific pathogen causing AOM.
Antibiotic selection by clinicians for
almost all episodes of AOM is empirical.
Most episodes of AOM usually result
from congestion of the eustachian tube
by an antecedent virus infection, which
then allows one or two of the four
typical aerobic bacteria, such as
Streptococcus pneumoniae, Haemophilus
influenzae, Moraxiella catarrhalis or
Streptococcus pyogenes, to ascend into the
middle ear space, causing the painful
purulent effusion of AOM. Viruses seem
to be an uncommon aetiology of AOM,
as positive cultures for viruses being the
sole pathogen of AOM occur in only 5–
6% of cases.1 2
How commonly do bacteria cause
AOM? Many multicentre studies report
bacterial culture-positive rates between
55% and 75% of children, depending on
whether the study is multinational or
from a single country or region.3–7 But,
the devil is in the details—that is, the
culture methods. Consequently, when
microbiologically rigorous clinical stu-
dies use a single tympanocentesis with
optimal bacterial culture techniques in
children with AOM, a bacterial patho-
gen is obtained in 87–95% of tympano-
centesis aspirates.5–7 Thus, AOM itself is
most always found to be caused by
bacteria—when stringent criteria to
diagnose AOM are used and highly
experienced investigators carry out tym-
panocentesis.
Can any dataset show the Holy Grail
of AOM? Can any physical or symptom
markers differentiate bacterial from
non-bacterial AOM, or Streptococcus pneu-
moniae from H influenzae or M catarrhalis?
Can any set of clinical or otological
scores evaluating severity of fever, irrit-
ability and tympanic membrane redness
and bulging differentiate the specific
bacterial pathogens of AOM? Remember
that families who participate in a study
that includes a single or a repeat
tympanocentesis would probably be
exceedingly motivated by the severity
of symptoms and the investigator’s
physical findings regarding this particu-
lar episode of AOM. So, as would be
expected, the mean symptom and tym-
panocentesis finding scores for any child
enrolled in this type of study would
initially be high. In addition second
tympanocentesis rarely shows much
microbiological information as well, as
a pathogen is rarely recovered in the
second tympanocentesis while receiving
antibiotics. On the other hand, over the
decades before the heptavalent pneu-
mococcal conjugate vaccine (PCV7)
became routine practice, some investi-
gators8 in the US had noted an almost
clinically significant difference between
children with AOM who had Streptococcus
pneumoniae versus those who had Gram-
negative pathogens. Children with
Streptococcus pneumoniae had a tendency
towards higher fever and more otalgia,
but the observed difference was not
enough to suggest that practitioners could
ignore the Gram-negative pathogens
when empirically selecting an antibiotic
for the ‘‘sicker’’ child with the AOM.
Enter the routine use of the heptava-
lent pneumococcal conjugate vaccine
since the summer of 2000 in the US
(and recently introduced in the UK).9
Preliminary investigational studies with
PCV7 showed merely a 6–7% reduction
in rates of overall AOM in the study
population,9 10 hardly perceptible by any
clinician. However, as people in entire
regions were vaccinated with the PCV7,
clinicians began reporting rates of AOM
reduction in the magnitude of up to 20%
among young children in certain pre-
dominantly white populations.11
Furthermore, our own rural Kentucky
general paediatric group has witnessed a
nearly 60% reduction in the rates of
sinusitis diagnosed in the first
36 months of life (unpublished data).
When PCV7 is routinely used, will it
also have an effect on the microbiology
of AOM? Resoundingly, yes. In the
1990s, Streptococcus pneumoniae was the
predominant pathogen of AOM,
accounting for nearly 50% of all AOM
isolates in the US and European coun-
tries, whereas H influenzae was usually
found in 30–35% of AOM cultures.12 13
By contrast, although the pneumococcal
conjugate vaccine has not been routi-
nely available in Israel, H influenzae has,
for unknown reasons,been the predo-
minant pathogen recovered in AOM for
years.14
The beneficial effects of PCV7 on
AOM have been further corroborated
by the shift in microbiology from two
geographically and demographically dis-
parate groups, who were predominantly
white and from communities where
PCV7 was routinely used. These recent
observational studies in the 2000s docu-
mented that the microbiology of AOM
from tympanocentesis aspirates has
shifted markedly towards Gram-nega-
tive pathogens among young children
who have received PCV7. Casey and
Pichichero15 along with Block and
cohorts,16 respectively, reported that of
the AOM isolates recovered, H influenzae
now accounts for about 56%,
Streptococcus pneumoniae for 31% and
high-level penicillin non-susceptible
Streptococcus pneumoniae (PNSP) for
about 5% of pathogens. Among H
influenzae isolates, b-lactamase produ-
cers were seen in 55% and 64%, respec-
tively, of H influenzae as well. The
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